Physician profile
Andrea Thomas
NPI 1356706568
$3,131.86
in general payments reported to CMS, 2019-2025
9 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $813 · 2022: $135 · 2023: $141 · 2024: $1,907 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265 · Travel and Lodging: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.99 |
| Travel and Lodging | $918.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,061.65 | 2021-2024 | Propel |
| Biohaven Pharmaceuticals, INC. | $408.56 | 2021 | |
| Janssen Pharmaceuticals, INC | $200.97 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $120.13 | 2023 | Rexulti |
| Braeburn INC. | $116.30 | 2025 | Brixadi |
| Esperion Therapeutics, INC. | $110.58 | 2021 | |
| Abbvie INC. | $52.39 | 2022 | |
| Integra Lifesciences Corporation | $37.38 | 2024-2025 | Tcc-Ez |
| Astrazeneca Pharmaceuticals LP | $23.90 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.